| Expression of pro-and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors DG Nowak, J Woolard, EM Amin, O Konopatskaya, MA Saleem, ... Journal of Cell Science 121 (20), 3487-3495, 2008 | 350 | 2008 |
| Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms a novel therapeutic strategy for angiogenesis DG Nowak, EM Amin, ES Rennel, C Hoareau-Aveilla, M Gammons, ... Journal of Biological Chemistry 285 (8), 5532-5540, 2010 | 223 | 2010 |
| WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing EM Amin, S Oltean, J Hua, MVR Gammons, M Hamdollah-Zadeh, ... Cancer Cell 20 (6), 768-780, 2011 | 207 | 2011 |
| Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression M Chen, CP Pratt, ME Zeeman, N Schultz, BS Taylor, A O'Neill, ... Cancer Cell 20 (2), 173-186, 2011 | 146 | 2011 |
| Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization S Senturk, NH Shirole, DG Nowak, V Corbo, A Vaughan, DA Tuveson, ... Nature Communications 8, doi:10.1038/ncomms14370, 2017 | 81 | 2017 |
| Myc drives Pten/ p53-deficient proliferation and metastasis due to Il6-secretion and Akt-suppression via Phlpp2. DG Nowak, H Cho, T Herzka, K Watrud, DV DeMarco, VM Wang, ... Cancer Discovery, 2015 | 48 | 2015 |
| Overexpression of VEGF165b in podocytes reduces glomerular permeability Y Qiu, J Ferguson, S Oltean, CR Neal, A Kaura, H Bevan, E Wood, ... Journal of the American Society of Nephrology 21 (9), 1498-1509, 2010 | 45 | 2010 |
| Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms J Woolard, W Vousden, SJ Moss, A Krishnakumar, MVR Gammons, ... Chemical Science 2 (2), 273-278, 2011 | 26 | 2011 |
| The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein M Chen, DG Nowak, N Narula, B Robinson, K Watrud, A Ambrico, ... Journal of Cell Biology 216 (3), 641-656, 2017 | 25 | 2017 |
| Molecular pathways: PI3K pathway phosphatases as biomarkers for cancer prognosis and therapy M Chen, DG Nowak, LC Trotman Clinical Cancer Research 20 (12), 3057-3063, 2014 | 25 | 2014 |
| Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output G Reyes, M Niederst, K Cohen-Katsenelson, JD Stender, MT Kunkel, ... Proceedings of the National Academy of Sciences 111 (38), E3957-E3965, 2014 | 21 | 2014 |
| The PHLPP2 phosphatase is a druggable driver of prostate cancer progression DG Nowak, KC Katsenelson, KE Watrud, M Chen, G Mathew, ... Journal of Cell Biol 218 (6), 1943-1957, 2019 | 17 | 2019 |
| Utility of single cell genomics in diagnostic evaluation of prostate cancer J Alexander, J Kendall, J McIndoo, L Rodgers, R Aboukhalil, D Levy, ... Cancer Research, 2017 | 16 | 2017 |
| Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors DP Labbé, DG Nowak, G Deblois, L Lessard, V Giguère, LC Trotman, ... Molecular Cancer Research 12 (2), 184-189, 2014 | 10 | 2014 |
David BatesUniversity of NottinghamVerifierad e-postadress på nottingham.ac.uk
